{"nct_id":"NCT05206591","title":"Study to Demonstrate the Efficacy and Safety of Secukinumab up to 224 Weeks in Subjects With Active Peripheral Spondyloarthritis (pSpA).","status":"WITHDRAWN","status_verified_date":"2023-01","start_date":"2022-08-16","start_date_type":"ESTIMATED","primary_completion_date":"2028-03-20","primary_completion_date_type":"ESTIMATED","completion_date":"2028-06-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}